NDC 47426-201 – Cinvanti

Aprepitant 130 mg/18mL · Injection, Emulsion · Intravenous

Human Prescription Drug

Product NDC47426-201

Product details

Brand name
Cinvanti
Generic name
Aprepitant
Labeler
Heron Therapeutics, Inc.
Dosage form
Injection, Emulsion
Route
Intravenous
Marketing category
NDA · NDA209296
Marketed since
January 3, 2018
Listing expires
December 31, 2027
Pharmacologic class
Substance P/Neurokinin-1 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Cinvanti →

Package NDC codes (1)

Package NDCDescriptionSince
47426-201-011 VIAL, GLASS in 1 CARTON (47426-201-01) / 18 mL in 1 VIAL, GLASSJan 3, 2018